Takeda Pharmaceutical Company Profile

Aggregated data from the web about Takeda Pharmaceutical

Company Name	Takeda Pharmaceutical
Website	https://en.wikipedia.org › wiki › Takeda_Pharmaceutical_Company
Snippet	It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by …
ISIN	JP3463000004
Type	Public KK
Owner	Nippon Life (6.79%)
Founded	1781
Founder	Chobei Takeda I
Revenue	¥1,770,531 million (FY 2018)[* 1]
Website	takeda.com
Formerly	Chobei Takeda & Co., Ltd. (1925-1943)Takeda Pharmaceutical Industries, Ltd. (English name only 1943-1961)Takeda Chemical Industries, Ltd. (English name only 1961-2004)[2]
Industry	Pharmaceuticals
Traded as	TYO: 4502, NAG: 4502, FSE: 4502, NYSE: TAK, Nikkei 225 component (TYO), TOPIX Core30 component (TYO)
Key people	Yasuchika Hasegawa(Chairman of the Board)Christophe Weber[3](President & CEO)
Net income	¥186,886 million (FY 2012)[* 1]
Native name	武田薬品工業株式会社
Headquarters	Nihonbashi, Chuo, Tokyo, Japan (global headquarters)[citation needed]
Total assets	¥4,106,463 billion (FY 2018)[* 1]
Total equity	¥1,997,424 billion (FY 2018)[* 1]
Romanized name	Takeda Yakuhin Kōgyō kabushiki gaisha
Operating income	¥241,789 million (FY 2018)[* 1]
Number of employees	49,578 (2019)

Takeda Pharmaceutical is part of the Japan company list

Takeda Pharmaceutical is part of the Pharmaceuticals company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.